![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 14, 2023 1:27:03 PM
"7 Common Paxlovid Interactions You Should Know About (Plus Other Medications to Avoid)
Joshua Murdock, PharmD, BCBBS
Christina Aungst, PharmD
Written by Joshua Murdock, PharmD, BCBBS | Reviewed by Christina Aungst, PharmD
Updated on March 3, 2023
Key takeaways:
Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral medication that’s authorized to treat certain people who have mild to moderate COVID-19.
Paxlovid interacts with many medications. Common examples are medications that treat high cholesterol, high blood pressure, and migraines. Other examples include antipsychotics and erectile dysfunction medications.
Your healthcare provider or pharmacist should screen for drug interactions before giving you Paxlovid. This is one of Paxlovid’s recommended prescribing steps.
If you have mild to moderate COVID-19, you may be eligible to receive a prescription for Paxlovid (nirmatrelvir/ritonavir)." (As I said, a covid diagnosis is no longer required)
https://www.goodrx.com/paxlovid/drug-interactions
You really need to read the linked article. I couldn't take Paxlovid because of some of the medications I'm already taking.
FDA has said they will continue to issue EUAs for covid therapeutics, even after the national emergency order expires. But, will they do that, if Paxlovid gets full approval?
They should. But it sure looks like they are trying to get this Paxlovid approval done before our ACTIV-5 results are reported.
What are things coming to? You can use paxlovid and molnupiravir, even without a COVID diagnosis? That's almost as non-sensical as the company's Twitter page featuring links to Follow guys that don't seem too interested in Humanigen anymore.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM